Glucocorticoid-induced osteoporosis: an update on effects and management.

Author: BinkleyNeil, BuehringBjoern, BusseWilliam, ViswanathanRavi

Paper Details 
Original Abstract of the Article :
Glucocorticoids remain a cornerstone of guideline-based management of persistent asthma and allergic diseases. Glucocorticoid-induced osteoporosis (GIO) is the most common iatrogenic cause of secondary osteoporosis and an issue of concern for physicians treating patients with inhaled or oral glucoco...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.jaci.2013.08.040

データ提供:米国国立医学図書館(NLM)

Glucocorticoid-Induced Osteoporosis: A Bone-Weakening Threat

The human skeletal system, like the strong and sturdy bones of a desert camel, plays a crucial role in maintaining our mobility and overall health. This study explores the risks and management strategies for glucocorticoid-induced osteoporosis (GIO), a common side effect of long-term glucocorticoid therapy. The researchers examine the underlying mechanisms of GIO and review the latest guidelines for diagnosis and treatment.

Understanding the Mechanism of GIO

The study reveals that glucocorticoids can negatively impact bone health by affecting the activity of osteoclasts, osteoblasts, and osteocytes, leading to bone loss and increased risk of fractures. The researchers emphasize the importance of early detection and management of GIO to prevent potentially debilitating fractures.

Implications for Osteoporosis Management

This research highlights the importance of considering bone health when prescribing long-term glucocorticoid therapy. Healthcare providers should carefully monitor bone mineral density in patients receiving these medications and implement preventative measures to minimize the risk of GIO.

Dr.Camel's Conclusion

The desert of osteoporosis research is a vital area of focus, as bone health is essential for overall well-being. This study underscores the importance of recognizing and managing the risks associated with GIO, ensuring that patients receiving glucocorticoids receive appropriate care and maintain strong and resilient bones.

Date :
  1. Date Completed 2014-01-07
  2. Date Revised 2022-03-31
Further Info :

Pubmed ID

24176682

DOI: Digital Object Identifier

10.1016/j.jaci.2013.08.040

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.